✦ LIBER ✦

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people

✍ Scribed by Åke Örtqvist; Jonas Hedlund; Lars-Åke Burman; Elisabet Elbel; Margareta Höfer; Maija Leinonen; Ingrid Lindblad; Bo Sundelöf; Mats Kalin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Revaccination with the 23-valent pneumoc

✍ Jan Törling; Jonas Hedlund; Helle Bossen Konradsen; Åke Örtqvist 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Clinical effectiveness of 23-valent pneu

✍ Angel Vila-Corcoles; Elisabet Salsench; Teresa Rodriguez-Blanco; Olga Ochoa-Gond 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Impact and effectiveness of 23-valent pn

✍ Nick J. Andrews; Pauline A. Waight; Robert C. George; Mary P.E. Slack; Elizabeth 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 265 KB

PIN74 A Cost-Effectiveness Analysis of V

✍ Y. Jiang; A. Gauthier; L. Annemans; M. van der Linden; L. Nicolas-Spony; X. Bres 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Efficacy of nine-valent pneumococcal con

✍ FT Cutts; SMA Zaman; G Enwere; S Jaffar; OS Levine; JB Okoko; C Oluwalana; A Vau 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 107 KB

PIN17 Modelling Budget Impact (BI) of Va

✍ Y. Jiang; A. Gauthier; L. Annemans; M. van der Linden; L. Nicolas-Spony; X. Bres 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB